For instance, expression of RIPK3 and other necroptotic adaptors in tumor cells was associated with improvement in CD8+ T cell infiltration in hepatocellular carcinoma (17), cholangiocarcinoma (18), and prostate cancer (19). This evidence concerns the gene CD8A and neoplasm.